Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats.
about
New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.New directions in nicotine vaccine design and use.Nicotine vaccines: will smokers take a shot at quitting?Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeuticLiposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.Scientific overview: 2013 BBC plenary symposium on tobacco addiction.Targeting nicotine addiction: the possibility of a therapeutic vaccine.Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats.Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategyEffects of active anti-methamphetamine vaccination on intravenous self-administration in rats.Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonistEffects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys.First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteersCurrent status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in ratsVaccination against nicotine: an emerging therapy for tobacco dependence.Nicotine vaccines to assist with smoking cessation: current status of research.[Immunotherapies for drug addictions].Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats.Changes in maternal and fetal nicotine distribution after maternal administration of monoclonal nicotine-specific antibody to rats.Development of active and passive human vaccines to treat methamphetamine addiction.Anti-drug vaccines to treat substance abuse.Nicotine vaccines to treat tobacco dependence.Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.Conjugate Vaccine Immunotherapy for Substance Use Disorder.Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alumStructurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities.Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats.Enhanced immunogenicity of a bivalent nicotine vaccineAcquisition of nicotine self-administration in adolescent rats given prolonged access to the drug.
P2860
Q28277165-0857B541-E2A4-4A80-BF08-9C4CDA5EF8C7Q33635666-1188D6FB-C5C7-4574-8CE0-8F28908DE993Q33719424-2184FBEC-C597-4025-A31A-1CC35CA11A71Q33759617-3B7A1E23-18CF-48F9-8EFA-634D4A929E84Q33932923-4BFAD4BB-28A9-460A-B04E-471F8530627BQ33994987-1CF8D950-9A79-4292-9C94-A8CF678F9977Q34329011-6506AD68-0B09-446D-9BDA-EB9416B0DC07Q34487271-B178DC14-4704-492C-8EEB-D8F444850607Q34987300-F15A07B4-8E97-40EA-90D0-1E08E607CAB9Q35207004-C149C941-AF8D-481A-A407-9FD3612C83B8Q35476326-7CE67F60-A291-4AE6-A528-44974AED535AQ35875875-5DB442E4-785A-4901-A0D1-638A9333ACE6Q35975765-DB088AB0-AA23-44BC-8AD8-9F04CDFE7EDBQ36184910-8E2BB798-1BD8-4E4B-AB8C-6D18047CE602Q36215915-11374F99-0C16-4990-A26E-CE986E443A76Q36439191-223ACAE6-19F5-4DA5-9C89-A5C6E7E5BC9BQ36579253-46F1C0F5-C357-405F-8837-DA290BFF7D44Q36985864-AD14B08F-6DD2-4B48-88ED-F8CD3D5204DCQ36987118-E4434000-6263-418A-884C-C167B99E067EQ37079788-E36B9AA5-97E2-4112-91D2-72C34DFD40A6Q37260093-41FDFD92-C443-41E8-ACFE-3C5DF593D356Q37306284-82CDA276-0021-4D33-8632-E2F4290B7F3DQ37411959-147555F2-FACD-405F-B218-EFC0CB39504BQ37427396-90398981-CE2D-4562-9094-5D714E813CB5Q38056382-07A9767D-9246-40CE-B1FF-823A5B5D8B5AQ39107792-C628FA78-E0C2-4DF4-A8D9-D56362B50C87Q39387013-13580199-F702-4C95-94CE-A6A8085B3856Q39556344-CC8A2251-FF00-4716-BB5D-6AC00F1BAB75Q40431126-0AE0A6B8-5E93-4BC7-A281-C945685084D9Q41959328-942E420E-D346-4C1A-B328-69BB2E67E8F7Q42583497-EBD0C6C7-E696-4048-9DA1-F6A40B19C6A2Q51798710-B87859CF-83C8-4822-81E5-4506ADB81A17
P2860
Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effects of a nicotine conjugat ...... e self-administration in rats.
@ast
Effects of a nicotine conjugat ...... e self-administration in rats.
@en
type
label
Effects of a nicotine conjugat ...... e self-administration in rats.
@ast
Effects of a nicotine conjugat ...... e self-administration in rats.
@en
prefLabel
Effects of a nicotine conjugat ...... e self-administration in rats.
@ast
Effects of a nicotine conjugat ...... e self-administration in rats.
@en
P2093
P1433
P1476
Effects of a nicotine conjugat ...... e self-administration in rats.
@en
P2093
Daniel E Keyler
Danielle Burroughs
Greg Collins
Mark G LeSage
Paul R Pentel
Yoko Hieda
P2888
P304
P356
10.1007/S00213-005-0027-2
P577
2005-07-01T00:00:00Z
P5875
P6179
1046405874